Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03087903 · ClinicalTrials.gov registry record · NA
A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03087903 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 41 participants.
The verdict
NCT03087903, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Patients will take 150 mg of GSE product by mouth twice daily and will be evaluated every 6 weeks for 3 months, then every 3 months thereafter for up to one year.
Interventions
- DIETARY_SUPPLEMENT Grape Seed Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-01-18 |
| Est. Completion | 2023-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03087903
The ClinicalTrials.gov registry entry for NCT03087903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Grape Seed Extract is the first listed.
NCT03087903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03087903 about?
NCT03087903 is a clinical study titled "A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA". Patients will take 150 mg of GSE product by mouth twice daily and will be evaluated every 6 weeks for 3 months, then every 3 months thereafter for up to one year.
What is the current status of trial NCT03087903?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2018-01-18. Estimated completion is 2023-09-29.
What interventions are being tested in trial NCT03087903?
The interventions under investigation include: Grape Seed Extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03087903?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.